WaveMan · Form 4
Leiden Jeffrey M insider trades
> Search tickers & screens ⌘K
LIVE

Leiden Jeffrey M insider trades

Leiden Jeffrey M has filed 28 Form 4s with the SEC that we hold, for Vertex Pharmaceuticals INC / Ma (VRTX) (Executive Chairman, Director) and Odyssey Therapeutics, Inc. (ODTX) (Director). Across all of them we count 1 purchase worth $100.0K and 42 sales worth $127.3M reported on Form 4. In the last 12 months: 1 purchase ($100.0K) and 17 sales ($60.9M). The largest single trade was a sale of 32,234 shares of Vertex Pharmaceuticals INC / Ma worth $14.2M, dated 2025-11-14. The first filing on our record is dated 2022-02-03 and the latest 2026-05-11.

Vertex Pharmaceuticals INC / Ma (VRTX)

Executive Chairman, Director · 27 filings · 42 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-04-13S, sale reported on Form 415,789$4.6M2022-04-14
2022-07-25S, sale reported on Form 440,666$11.5M2022-07-27
2022-07-25S, sale reported on Form 434,090$9.6M2022-07-27
2022-07-25S, sale reported on Form 432,983$9.2M2022-07-27
2022-07-25S, sale reported on Form 413,869$3.9M2022-07-27
2022-07-25S, sale reported on Form 410,471$3.0M2022-07-27
2023-05-02S, sale reported on Form 44,645$1.6M2023-05-04
2023-05-02S, sale reported on Form 41,505$527.5K2023-05-04
2023-05-02S, sale reported on Form 4300$106.0K2023-05-04
2023-05-03S, sale reported on Form 42,008$701.2K2023-05-04
2023-05-03S, sale reported on Form 41,800$631.0K2023-05-04
2023-05-03S, sale reported on Form 4700$246.1K2023-05-04
2023-05-05S, sale reported on Form 4171$59.9K2023-05-09
2023-05-05S, sale reported on Form 4708$247.4K2023-05-09
2023-05-08S, sale reported on Form 41,125$392.6K2023-05-09
2023-10-16S, sale reported on Form 412,962$4.8M2023-10-18
2023-12-13S, sale reported on Form 4100$40.0K2023-12-15
2023-12-13S, sale reported on Form 413,254$5.3M2023-12-15
2024-01-08S, sale reported on Form 46,648$2.8M2024-01-10
2024-02-12S, sale reported on Form 4647$272.0K2024-02-14
2024-02-12S, sale reported on Form 42,009$842.2K2024-02-14
2024-02-13S, sale reported on Form 4737$308.9K2024-02-14
2024-02-14S, sale reported on Form 44,356$1.8M2024-02-16
2024-02-15S, sale reported on Form 44,655$2.0M2024-02-16
2024-08-30S, sale reported on Form 43,784$1.9M2024-09-04
2025-11-13S, sale reported on Form 418,528$8.2M2025-11-17
2025-11-13S, sale reported on Form 41,160$511.6K2025-11-17
2025-11-14S, sale reported on Form 440$17.7K2025-11-17
2025-11-14S, sale reported on Form 432,234$14.2M2025-11-17
2025-11-14S, sale reported on Form 421,330$9.4M2025-11-17
2025-12-03S, sale reported on Form 47,899$3.5M2025-12-05
2025-12-03S, sale reported on Form 410,360$4.7M2025-12-05
2025-12-03S, sale reported on Form 415,681$7.1M2025-12-05
2025-12-03S, sale reported on Form 45,809$2.6M2025-12-05
2025-12-03S, sale reported on Form 45,880$2.6M2025-12-05
2025-12-03S, sale reported on Form 42,320$1.0M2025-12-05
2025-12-03S, sale reported on Form 41,152$515.0K2025-12-05
2025-12-03S, sale reported on Form 42,070$942.3K2025-12-05
2025-12-03S, sale reported on Form 44,469$2.0M2025-12-05
2025-12-03S, sale reported on Form 41,320$582.5K2025-12-05
2025-12-03S, sale reported on Form 42,469$1.1M2025-12-05
2025-12-03S, sale reported on Form 44,352$1.9M2025-12-05

Odyssey Therapeutics, Inc. (ODTX)

Director · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-05-08P, purchase reported on Form 45,000$100.0K2026-05-11
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1242825) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms